Ignite Creation Date:
2025-12-24 @ 6:59 PM
Ignite Modification Date:
2025-12-29 @ 2:11 AM
Study NCT ID:
NCT01552057
Status:
COMPLETED
Last Update Posted:
2015-01-16
First Post:
2012-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study of Duloxetine in Fibromyalgia
Sponsor:
Eli Lilly and Company
Organization:
Study Overview
Official Title:
A Phase III Clinical Trial of Duloxetine in Participants With Fibromyalgia
Status:
COMPLETED
Status Verified Date:
2015-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of the study is to assess the effectiveness and safety of duloxetine in participants with fibromyalgia.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
Secondary ID Infos
| Secondary ID | Type | Domain | Link | View |
|---|---|---|---|---|
| F1J-JE-HMGZ | OTHER | Eli Lilly and Company | View |